Of 95 patients receiving transthoracic shocks for atrial flutter in the emergency department, about half were treated with a defibrillator that delivered monophasic-waveform shocks and the rest were ...

May 2, 2003 - A retrospective study and results of a phase 3 trial point to new approaches to both short-term cardioversion and long-term maintenance of patients with atrial fibrillation (AF).

When atrial flutter is seen with such a slow ventricular response (in this case, 9:1 conduction), there is concern for underlying complete heart block should the patient be restored to normal sinus ...

Clinical trial finds edoxaban to be equally effective as current use of warfarin. Clinical trial finds edoxaban to be equally effective as current use of warfarin. The results of the largest known ...

Please provide your email address to receive an email when new articles are posted on . Sinus rhythm was restored in an effective, safe and rapid manner using drug-shock or shock-only strategies among ...

Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with atrial fibrillation scheduled for elective cardioversion, according to new research. Apixaban lowers the ...

A team of Ochsner Health cardiologists recently published an article in the Journal of the American Medical Association (JAMA) Cardiology comparing two treatment strategies for patients with atrial ...